<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>c52191_10-q.htm
<TEXT>

<HTML>
<HEAD>
   <TITLE> -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">




<P align="justify">
<B><FONT size=2 face="serif">FORM 10-Q </FONT></B><B><I><FONT size=2 face="serif"> </FONT></I></B><BR>
<B><FONT size=2 face="serif">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</FONT></B><FONT size=2 face="serif"> </FONT><BR>
<B><FONT size=2 face="serif">WASHINGTON, D.C. 20549 </FONT></B></P>
<P align="justify">
<FONT size=2 face="serif">(Mark One)</FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
<TD width=51 align=left nowrap>
<FONT size=2 face="serif">[X]</FONT></TD>
<TD align=left nowrap colspan=2>
<FONT size=2 face="serif">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</FONT></TD>
</TR>

<TR valign="bottom">
  <TD width="51" align=left nowrap>&nbsp;</TD>
  <TD width="98" align=left nowrap>&nbsp;</TD>
  <TD width="873" align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap colspan=2>
<FONT size=2 face="serif">For the quarterly period ended</FONT></TD>
<TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">December 31, 2007&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
</TR>
<TR valign="bottom">
  <TD width="51" align=center nowrap>&nbsp;</TD>
  <TD colspan="2" align=center nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width="51" colspan="3" align=center nowrap>
    <FONT size=2 face="serif">OR</FONT></TD>
  </TR>
<TR valign="bottom">
  <TD width="51" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap colspan=2>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width="51" align=left nowrap>
<FONT size=2 face="serif">[&nbsp;&nbsp; ]</FONT></TD>
<TD align=left nowrap colspan=2>
<FONT size=2 face="serif">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934</FONT></TD>
</TR>
</TABLE>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
</table>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="14%" nowrap><FONT size=2 face="serif">For the transition period from&nbsp;</FONT></td>
    <td width="42%"><div style="border-bottom:1px solid #000000"> &nbsp;</div></td>
    <td width="1%"><FONT size=2 face="serif">&nbsp;to&nbsp;</FONT></td>
    <td width="42%"><div style="border-bottom:1px solid #000000"> &nbsp;</div>
      </td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="13%" nowrap><FONT size=2 face="serif">Commission file number&nbsp;</FONT></td>
    <td width="12%" align=center style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">001-4802</FONT></td>
    <td width="78%">&nbsp;</td>
  </tr>
</table>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD align=center nowrap colspan=3>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align=center nowrap colspan=3 style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">Becton, Dickinson and Company</FONT></TD>
  </TR>
<TR valign="bottom">
<TD align=center nowrap colspan=3>
<FONT size=2 face="serif">(Exact name of registrant as specified in its charter)</FONT></TD>
</TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width="15%" align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">New Jersey</FONT></TD>
<TD width="65%">&nbsp;</TD>
<TD width="20%" align=center nowrap style="border-bottom:1px solid #000000;">
    <FONT size=2 face="serif">22-0760120</FONT></TD>
  </TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">(State or other jurisdiction of</FONT></TD>
<TD>&nbsp;</TD>
<TD align=center nowrap>
<FONT size=2 face="serif">(I.R.S. Employer Identification No.)</FONT></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>&nbsp;<FONT size=2 face="serif">incorporation or organization)</FONT></TD>
<TD>&nbsp;</TD>
<TD align=right nowrap>&nbsp;</TD>
  </TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR></table>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="36%">&nbsp;</td>
    <td align=center style="border-bottom:1px solid #000000;"><FONT size=2 face="serif" >1 Becton Drive, Franklin Lakes, New Jersey
    07417-1880</FONT></td>
    <td width="36%">&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align=center><FONT size=2 face="serif">(Address of principal executive offices)</FONT></td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align=center><FONT size=2 face="serif">(Zip Code)</FONT></td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align=center style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(201) 847-6800</FONT></td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align=center><FONT size=2 face="serif">(Registrant's telephone number, including area
    code)</FONT></td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align=center style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">N/A</FONT></td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align=center><FONT size=2 face="serif">(Former name, former address and former fiscal
    year,</FONT></td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align=center><FONT size=2 face="serif">if changed since last report)</FONT></td>
    <td>&nbsp;</td>
  </tr>
</TABLE>
<BR>
<P align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the  registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yes&nbsp;&nbsp;</FONT><font face=WINGDINGS>x  </FONT><FONT size=2 face="sans-serif">   &nbsp;&nbsp;&nbsp;&nbsp; No </FONT><font face=WINGDINGS>o</font> </P>

<P align="justify">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in
Rule 12b-2 of the Exchange Act. (Check one):  </FONT><br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Large
accelerated filer&nbsp;&nbsp;</FONT><font face=WINGDINGS>x</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <FONT size=2 face="serif">Accelerated
filer </FONT><font face=WINGDINGS>o</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <FONT size=2 face="serif">
  Non-accelerated filer </FONT><font face=WINGDINGS>o</font></P>

<P align="justify">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Indicate
  by checkmark whether the registrant is a shell company (as defined in Rule
  12b-2 of the Exchange Act). Yes </FONT><FONT FACE=WINGDINGS>o</FONT>  <FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  No&nbsp;</FONT><font face=WINGDINGS>x</font> </P>

<P align="justify">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Indicate
  the number of shares outstanding of each of the issuer's classes of common
  stock, as of the latest practicable date.</FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
  <tr valign="bottom">
    <td width="15%" align=center nowrap style="border-bottom:1px solid #000000;"><font size=2 face="serif">Class
        of Common Stock</font></td>
    <td width="58%">&nbsp;</td>
    <td width="27%" align=center nowrap style="border-bottom:1px solid #000000;"><font size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares
        Outstanding as of December 31, 2007&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
  </tr>
  <tr valign="bottom">
    <td width="15%" align=left nowrap><font size=2 face="serif">Common stock,
        par value $1.00</font></td>
    <td>&nbsp;</td>
    <td width="27%" align=center nowrap><font size=2 face="serif">244,055,592</font></td>
  </tr>
<TR valign="bottom"></TR>
</TABLE>
<BR>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="center">
<FONT size=2 face="serif">BECTON, DICKINSON AND COMPANY </FONT><BR>
<FONT size=2 face="serif">FORM 10-Q </FONT><BR>
<FONT size=2 face="serif">For the quarterly period ended December 31, 2007 </FONT><BR>
<BR>
<FONT size=2 face="serif">TABLE OF CONTENTS</FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<U><FONT size=2 face="serif">Part I.</FONT></U></TD>
<TD  width=1%>&nbsp;</TD>
<TD align=left nowrap>
<U><FONT size=2 face="serif">FINANCIAL INFORMATION</FONT></U></TD>
<TD  width=1%>&nbsp;</TD>
<TD width=11% align=center nowrap>
<U><FONT size=2 face="serif">Page Number</FONT></U></TD>
</TR>
<TR>
<TD colspan=5>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Item 1.</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Financial Statements (Unaudited)</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Condensed Consolidated Balance Sheets</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">3</FONT></TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Condensed Consolidated Statements of Income</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">4</FONT></TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Condensed Consolidated Statements of Cash Flows</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">5</FONT></TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Notes to Condensed Consolidated Financial Statements</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">6</FONT></TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Item 2.</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap><FONT size=2 face="serif">16</FONT></TD>
</TR>

<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Item 3.</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Quantitative and Qualitative Disclosures About Market Risk</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">23</FONT></TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Item 4.</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Controls and Procedures</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">23</FONT></TD>
</TR>
<TR>
<TD colspan=5>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<U><FONT size=2 face="serif">Part II.</FONT></U></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<U><FONT size=2 face="serif">OTHER INFORMATION</FONT></U></TD>
<TD>&nbsp;</TD>
<TD width=11% align=left nowrap>&nbsp;</TD>
</TR>
<TR>
<TD colspan=5>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Item 1.</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Legal Proceedings</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">24</FONT></TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Item 1A.</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Risk Factors</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">25</FONT></TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Item 2.</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Unregistered Sales of Equity Securities and Use of Proceeds</FONT></TD>
<TD>&nbsp;</TD>
<TD align=center nowrap><FONT size=2 face="serif">25</FONT></TD>
</TR>

<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Item 3.</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Defaults Upon Senior Securities</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">25</FONT></TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Item 4.</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Submission of Matters to a Vote of Security Holders</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">25</FONT></TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Item 5.</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Other Information</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">27</FONT></TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Item 6.</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Exhibits</FONT></TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">27</FONT></TD>
</TR>
<TR>
<TD colspan=5>&nbsp;</TD>
</TR>
<TR>
<TD colspan=5>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Signatures</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">28</FONT></TD>
</TR>
<TR>
<TD colspan=5>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width=11% align=left nowrap>
<FONT size=2 face="serif">Exhibits</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD width=11% align=center nowrap>
<FONT size=2 face="serif">29</FONT></TD>
</TR>
</TABLE>
<BR>
<P align="center">
<FONT size=2 face="serif">2</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="center">
<FONT size=2 face="serif">ITEM 1. FINANCIAL STATEMENTS </FONT><BR>
<FONT size=2 face="serif">BECTON, DICKINSON AND COMPANY </FONT><BR>
<FONT size=2 face="serif">CONDENSED CONSOLIDATED BALANCE SHEETS </FONT><BR>
<FONT size=2 face="serif">Thousands of dollars </FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD colspan="3" align=center nowrap><FONT size=2 face="serif">December 31,</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD colspan="3" align=center nowrap><FONT size=2 face="serif">September 30,</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><U><FONT size=2 face="serif">Assets</FONT></U></TD>
    <TD width="1%">&nbsp;</TD>
    <TD colspan="3" align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2007</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD colspan="3" align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2007</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD colspan="3" align=center nowrap><FONT size=2 face="serif">(Unaudited)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Current Assets:</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Cash and
        equivalents</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD width="8%" align=right nowrap><FONT size=2 face="serif">750,762</FONT></TD>
    <TD width="1%" align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD width="8%" align=right nowrap><FONT size=2 face="serif">511,482</FONT></TD>
    <TD width="1%" align=left nowrap></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Short-term
        investments</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">168,875</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">158,040</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Trade receivables,
        net</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">1,020,751</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">1,083,152</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Inventories:</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Materials</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">146,387</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">142,484</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Work
        in process</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">203,649</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">195,155</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Finished
        products</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">729,959</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">714,320</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">1,079,995</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">1,051,959</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Prepaid expenses, deferred
        taxes and other</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">324,684</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">325,933</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Total
        Current Assets</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">3,345,067</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">3,130,566</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR>
    <TD colspan=9>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Property, plant and equipment</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">5,468,174</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">5,354,115</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Less allowances
        for depreciation and amortization</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2,924,175</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2,856,777</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">2,543,999</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">2,497,338</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Goodwill</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">621,587</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">621,414</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Core and Developed Technology,
        Net</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">364,294</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">374,779</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Other Intangibles, Net</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">93,868</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">95,938</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Capitalized Software, Net</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">130,868</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">142,738</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Other</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">466,851</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">466,592</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Total
        Assets</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">7,566,534</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">7,329,365</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><U><FONT size=2 face="serif">Liabilities and Shareholders&#146; Equity</FONT></U></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR>
    <TD colspan=9>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Current Liabilities:</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Short-term
        debt</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">208,206</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">207,634</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Payables
        and accrued expenses</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,288,600</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,271,175</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Total
        Current Liabilities</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">1,496,806</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">1,478,809</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Long-Term Debt</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">957,627</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">955,713</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Long-Term Employee Benefit
        Obligations</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">427,610</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">444,874</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Deferred Income Taxes and
        Other</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">160,215</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">88,012</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Commitments and Contingencies</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">-</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">-</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Shareholders&#146; Equity:</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Common
        stock</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">332,662</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">332,662</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Capital
        in excess of par value</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">1,189,584</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">1,125,368</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Retained
        earnings</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">6,191,051</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">5,995,787</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Deferred
        compensation</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">14,837</FONT></TD>
    <TD align=left nowrap></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">12,205</FONT></TD>
    <TD align=left nowrap></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Common
        shares in treasury &#150; at cost</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(3,237,074</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(3,105,893</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Accumulated
        other comprehensive income</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">33,216</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,828</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Total
        Shareholders&#146; Equity</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">4,524,276</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">4,361,957</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Total
        Liabilities and Shareholders&#146; Equity</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">7,566,534</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">7,329,365</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;">&nbsp;</TD>
  </TR>
</TABLE>
<BR>
<P align="left">
<FONT size=2 face="serif">See notes to condensed consolidated financial statements </FONT></P>
<P align="center">
<FONT size=2 face="serif">3</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="center">
<FONT size=2 face="serif">BECTON, DICKINSON AND COMPANY </FONT><BR>
<FONT size=2 face="serif">CONDENSED CONSOLIDATED STATEMENTS OF INCOME </FONT><BR>
<FONT size=2 face="serif">Thousands of dollars, except per share data </FONT><BR>
<FONT size=2 face="serif">(Unaudited) </FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
<TD align=left nowrap></TD>
<TD></TD>
<TD colspan="7" align=center nowrap><FONT size=2 face="serif">Three Months Ended</FONT></TD>
  </TR>
<TR valign="bottom">
<TD align=left nowrap></TD>
<TD></TD>
<TD colspan="7" align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">December 31,</FONT></TD>
  </TR>
<TR valign="bottom">
<TD align=left nowrap>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
<TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2007</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
<TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2006</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Revenues</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
<TD align=right nowrap>
<FONT size=2 face="serif">1,705,767</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">$</FONT></TD>
<TD align=right nowrap>
<FONT size=2 face="serif">1,501,526</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR>
<TD colspan=9>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
<TD align=left nowrap>
<FONT size=2 face="serif">Cost of products sold</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">829,846</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">708,933</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Selling and administrative</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">421,718</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">384,084</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
<TD align=left nowrap>
<FONT size=2 face="serif">Research and development</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">91,527</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">79,940</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Acquired in-process research and development</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">-</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">114,739</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
<TD align=left nowrap>
<FONT size=2 face="serif">Total Operating Costs and Expenses</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,343,091</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,287,696</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR>
<TD colspan=9>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Operating Income</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">362,676</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">213,830</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR>
<TD colspan=9>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
<TD align=left nowrap>
<FONT size=2 face="serif">Interest income</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">13,528</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">16,114</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Interest expense</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">(10,339</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">(12,868</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
<TD align=left nowrap>
<FONT size=2 face="serif">Other income (expense), net</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">707</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(2,368</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
</TR>
<TR>
<TD colspan=9>&nbsp;</TD>
</TR>

<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Income From Continuing Operations Before Income Taxes</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">366,572</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">214,708</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR>
<TD colspan=9>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
<TD align=left nowrap>
<FONT size=2 face="serif">Income tax provision</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">95,676</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">83,657</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR>
<TD colspan=9>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Income From Continuing Operations</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">270,896</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">131,051</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR>
<TD colspan=9>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
<TD align=left nowrap>
<FONT size=2 face="serif">Income from Discontinued Operations, net</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">652</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">11,828</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Net Income</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
<TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">271,548</FONT></TD>
<TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">$</FONT></TD>
<TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">142,879</FONT></TD>
<TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
<TD align=left nowrap>
<U><FONT size=2 face="serif">Basic Earnings per Share:</FONT></U></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Income from Continuing Operations</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
<TD align=right nowrap>
<FONT size=2 face="serif">1.11</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">$</FONT></TD>
<TD align=right nowrap>
<FONT size=2 face="serif">0.53</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
<TD align=left nowrap>
<FONT size=2 face="serif">Income from Discontinued Operations</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">-</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">0.05</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Basic Earnings per Share</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
<TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">1.11</FONT></TD>
<TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">$</FONT></TD>
<TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">0.58</FONT></TD>
<TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
<TD align=left nowrap>
<U><FONT size=2 face="serif">Diluted Earnings per Share:</FONT></U></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Income from Continuing Operations</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
<TD align=right nowrap>
<FONT size=2 face="serif">1.07</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">$</FONT></TD>
<TD align=right nowrap>
<FONT size=2 face="serif">0.51</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
<TD align=left nowrap>
<FONT size=2 face="serif">Income from Discontinued Operations</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">-</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">0.05</FONT></TD>
<TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Diluted Earnings per Share</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
<TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">1.07</FONT></TD>
<TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">$</FONT></TD>
<TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">0.56</FONT></TD>
<TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
<TD align=left nowrap>
<FONT size=2 face="serif">Dividends per Common Share</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD width="1%" align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
<TD width="8%" align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">0.285</FONT></TD>
<TD width="1%" align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
<TD width="5%">&nbsp;</TD>
<TD width="1%" align=left nowrap>
<FONT size=2 face="serif">$</FONT></TD>
<TD width="8%" align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">0.245</FONT></TD>
<TD width="1%" align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
</TR>
</TABLE>
<BR>
<P align="left">
<FONT size=2 face="serif">See notes to condensed consolidated financial statements </FONT></P>
<P align="center">
<FONT size=2 face="serif">4</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="center">
<FONT size=2 face="serif">BECTON, DICKINSON AND COMPANY </FONT><BR>
<FONT size=2 face="serif">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </FONT><BR>
<FONT size=2 face="serif">Thousands of dollars </FONT><BR>
<FONT size=2 face="serif">(Unaudited) </FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
  <TR valign="bottom">
    <TD align=left nowrap></TD>
    <TD></TD>
    <TD colspan="7" align=center nowrap><FONT size=2 face="serif">Three Months
        Ended</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap></TD>
    <TD></TD>
    <TD colspan="7" align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">December
    31,</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2007</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2006</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><U><FONT size=2 face="serif">Operating Activities</FONT></U></TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
    <TD width="8%" align=left nowrap>&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
    <TD width="8%" align=left nowrap>&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Net income</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">271,548</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">142,879</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Income from discontinued
        operations, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(652</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(11,828</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Income from continuing operations</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">270,896</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">131,051</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Adjustments to income from
        continuing operations to derive net cash</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">provided
        by continuing operating activities, net of amounts acquired:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Depreciation
        and amortization</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">115,212</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">101,081</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Share-based
        compensation</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">35,666</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">34,611</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Deferred
        income taxes</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(1,473</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(27,457</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Acquired
        in-process research and development</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">-</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">114,739</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Change
        in working capital</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">52,788</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(23,579</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Pension
        obligation</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(12,930</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(67,973</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Other,
        net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">12,973</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">13,599</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Net
        Cash Provided by Continuing Operating Activities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">473,132</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">276,072</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR>
    <TD colspan=9>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><U><FONT size=2 face="serif">Investing Activities</FONT></U></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Capital expenditures</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(121,176</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(110,579</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Capitalized software</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(4,140</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(5,405</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Purchases of investments,
        net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(4,752</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(1,587</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Acquisitions of businesses,
        net of cash acquired</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">-</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(339,528</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Proceeds from discontinued
        operations</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">-</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">19,971</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Other, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(8,662</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(12,415</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Net
        Cash Used for Continuing Investing Activities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(138,730</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(449,543</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR>
    <TD colspan=9>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><U><FONT size=2 face="serif">Financing Activities</FONT></U></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Change in short-term debt</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">532</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(122,246</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Payments of debt</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(236</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(99,948</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Repurchase of common stock</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(122,747</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(112,329</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Excess tax benefits from
        payments under share-based compensation plans</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">24,920</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">9,454</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Issuance of common stock
        and other, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(3,547</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">19,101</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Net
        Cash Used for Continuing Financing Activities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(101,078</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(305,968</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR>
    <TD colspan=9>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><U><FONT size=2 face="serif">Discontinued Operations</FONT></U></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Net cash provided by operating
        activities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">26</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">9,487</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR>
    <TD colspan=9>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Effect of exchange rate changes
        on cash and equivalents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">5,930</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">3,088</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Net
        increase (decrease) in cash and equivalents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">239,280</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(466,864</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR>
    <TD colspan=9>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Opening Cash and Equivalents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">511,482</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,000,289</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Closing Cash and Equivalents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">750,762</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">533,425</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
</TABLE>
<BR>
<P align="left">
<FONT size=2 face="serif">See notes to condensed consolidated financial statements</FONT><FONT size=2 face="monospace"> </FONT></P>
<P align="center">
<FONT size=2 face="serif">5</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="center">
<FONT size=2 face="serif">BECTON, DICKINSON AND COMPANY </FONT><BR>
<FONT size=2 face="serif">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </FONT><BR>
<FONT size=2 face="serif">Dollar and share amounts in thousands, except per share data </FONT><BR>
<FONT size=2 face="serif">December 31, 2007 </FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Note 1 - Basis of Presentation</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, in the opinion of the management of the Company, include all adjustments which
are of a normal recurring nature, necessary for a fair presentation of the financial position and the results of operations and cash flows for the periods presented.  However, the financial statements do not include all information and footnotes
required for a presentation in accordance with U.S. generally accepted accounting principles. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included
or incorporated by reference in the Company's 2007 Annual Report on Form 10-K. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.</FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Note 2 &#150; Accounting Change</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">On October 1, 2007, the Company adopted Financial Accounting
Standards Board Interpretation No. 48 &#147;Accounting for Uncertainty in Income
Taxes, an interpretation of FASB Statement No. 109&#148; (&#147;FIN 48&#148;).
FIN 48 provides guidance for the financial statement recognition and measurement
of a tax position taken or expected to be taken in a tax return. As a result
of the implementation of FIN 48, the Company recognized a $5,083 increase in
its existing liability for uncertain tax positions, with a corresponding decrease
to the October 1, 2007 retained earnings balance. The Company also reclassified
the total amount of unrecognized tax benefits of $71,782 from a current liability
account (Payables and accrued expenses) to a non-current liability account (Deferred
Income Taxes and Other) on the Condensed Consolidated Balance Sheets, in accordance
with FIN 48. If the Company were to recognize the unrecognized tax benefits,
the effective tax rate would be favorably impacted. The Company does not anticipate
any significant changes over the next 12 months to the amount of unrecognized
tax benefits. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The Company includes interest and penalties associated with unrecognized tax benefits as a component of the Income tax provision on the Condensed Consolidated Statements of Income. Accrued interest and penalties related to
unrecognized tax benefits, included in the total amount, were $9,388. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions.  The U.S. Internal Revenue Service (&#147;IRS&#148;) has completed its
audit for the tax years through 2002; however, the tax years 2000 through 2002 remain open, with a single issue being considered in the IRS administrative appeals process. For the Company&#146;s other major tax jurisdictions where it conducts
business, the Company&#146;s tax years are generally open after 2001. </FONT></P>
<P align="center">
<FONT size=2 face="serif">6</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<U><FONT size=2 face="serif">Note 3 &#150; Comprehensive Income</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">Comprehensive income was comprised of the following: </FONT></P>
<TABLE width="75%" border=0 cellpadding=0 cellspacing=0>
  <TR valign="bottom">
    <TD align=left nowrap></TD>
    <TD></TD>
    <TD align=center nowrap colspan=7><FONT size=2 face="serif">Three Months
        Ended</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap></TD>
    <TD></TD>
    <TD align=center nowrap colspan=7 style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">December
        31,</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2007</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2006</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Net Income</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD width="8%" align=right nowrap><FONT size=2 face="serif">271,548</FONT></TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD width="8%" align=right nowrap><FONT size=2 face="serif">142,879</FONT></TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Other Comprehensive Income
        (Loss), Net of Tax</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Foreign
        currency translation adjustments</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">28,248</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">75,477</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Benefit
        plans adjustment</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">1,831</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">-</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Unrealized
        losses on investments,</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">net
        of amounts reclassified</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">-</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(10,397</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Unrealized
        gains (losses) on cash flow</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">hedges,
        net of amounts realized</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,309</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(1,726</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">31,388</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">63,354</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Comprehensive Income</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">302,936</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">206,233</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
</TABLE>
<BR>
<P align="justify">
<FONT size=2 face="serif">The amount of unrealized losses or gains on investments and cash flow hedges in comprehensive income has been adjusted to reflect any realized gains and recognized losses included in net income during the three months ended
December 31, 2007 and 2006.  The change in foreign currency translation adjustments is primarily attributable to stronger European currencies versus the U.S. dollar for the three months ended December 31, 2007 and 2006. </FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Note 4 - Earnings per Share</FONT></U><B><I><FONT size=2 face="serif"> </FONT></I></B></P>
<P align="justify">
<FONT size=2 face="serif">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows: </FONT></P>
<TABLE width="75%" border=0 cellpadding=0 cellspacing=0>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=center nowrap colspan=6><FONT size=2 face="serif">Three Months
        Ended</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=center nowrap colspan=6 style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">December
        31,</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2007</FONT></TD>
    <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2006</FONT></TD>
    <TD width="1%" align=center nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Average common shares outstanding</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="8%" align=right nowrap><FONT size=2 face="serif">244,292</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="8%" align=right nowrap><FONT size=2 face="serif">&nbsp; 245,550</FONT></TD>
    <TD align=right nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Dilutive share equivalents
        from</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">share-based
        plans</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">8,824</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">9,391</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Average common and common</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">equivalent
        shares outstanding &#150;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">assuming
    dilution</FONT></TD>
    <TD></TD>
    <TD></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">253,116</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%"></TD>
    <TD>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp; 254,941</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;">&nbsp;</TD>
  </TR>
</TABLE>
<BR>
<P align="center">
<FONT size=2 face="serif">7</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<U><FONT size=2 face="serif">Note 5 - Contingencies</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The Company is named as a defendant in five purported class action suits brought on behalf of direct purchasers of the Company&#146;s products, such as distributors, alleging that the Company violated federal antitrust
laws, resulting in the charging of higher prices for the Company&#146;s products to the plaintiff and other purported class members.  The cases filed are as
follows:</FONT></P>
<I><FONT size=2 face="serif">Louisiana Wholesale Drug Company, Inc., et. al. vs. Becton Dickinson and Company </FONT></I><FONT size=2 face="serif">(Civil Action No. 05-1602, U.S. District Court, Newark, New Jersey), filed on March 25, 2005;
</FONT><I><FONT size=2 face="serif">SAJ Distributors, Inc. et. al. vs. Becton Dickinson &amp; Co. </FONT></I><FONT size=2 face="serif">(Case 2:05-CV-04763-JD, United States District Court, Eastern District of Pennsylvania), filed on September 6,
2005; </FONT><I><FONT size=2 face="serif">Dik Drug Company, et. al. vs. Becton, Dickinson and Company</FONT></I><FONT size=2 face="serif"> (Case No. 2:05-CV-04465, U.S. District Court, Newark, New Jersey), filed on September 12, 2005;
</FONT><I><FONT size=2 face="serif">American Sales Company, Inc. et. al. vs. Becton, Dickinson &amp; Co.</FONT></I><FONT size=2 face="serif"> (Case No. 2:05-CV-05212-CRM, U.S. District Court, Eastern District of Pennsylvania), filed on October 3,
2005; and </FONT><I><FONT size=2 face="serif">Park Surgical Co. Inc. et. al. vs. Becton, Dickinson and Company</FONT></I><FONT size=2 face="serif"> (Case 2:05-CV-05678-CMR, United States District Court, Eastern District of Pennsylvania), filed on
October 26, 2005.</FONT></P>
<P align="justify">
<FONT size=2 face="serif">The actions brought by Louisiana Wholesale Drug Company and Dik Drug Company in New Jersey have been consolidated under the caption &#147;</FONT><I><FONT size=2 face="serif">In re Hypodermic Products Antitrust
Litigation</FONT></I><FONT size=2 face="serif">.&#148;</FONT></P>
<P align="justify">
<FONT size=2 face="serif">The Company is also named as a defendant in four purported class action suits brought on behalf of indirect purchasers of the Company&#146;s products, alleging that the Company violated federal antitrust laws, resulting in
the charging of higher prices for the Company&#146;s products to the plaintiff and other purported class members. The cases filed are as follows: </FONT><I><FONT size=2 face="serif">Jabo&#146;s Pharmacy, Inc., et. al. v. Becton Dickinson &amp;
Company</FONT></I><FONT size=2 face="serif"> (Case No. 2:05-CV-00162, United States District Court, Greenville, Tennessee) filed on June 7, 2005;</FONT><I><FONT size=2 face="serif"> Drug Mart Tallman, Inc., et. al. v. Becton Dickinson and
Company</FONT></I><FONT size=2 face="serif"> (Case No. 2:06-CV-00174, U.S. District Court, Newark, New Jersey), filed on January 17, 2006; </FONT><I><FONT size=2 face="serif">Medstar v. Becton Dickinson</FONT></I><FONT size=2 face="serif"> (Case No.
06-CV-03258-JLL (RJH), U.S. District Court, Newark, New Jersey), filed on May 18, 2006; and </FONT><I><FONT size=2 face="serif">The Hebrew Home for the Aged at Riverdale v. Becton Dickinson and Company</FONT></I><FONT size=2 face="serif"> (Case No.
07-CV-2544, U.S. District Court, Southern District of New York), filed on March 28, 2007. A fifth purported class action on behalf of indirect purchasers (</FONT><I><FONT size=2 face="serif">International Multiple Sclerosis Management Practice v.
Becton Dickinson &amp; Company</FONT></I><FONT size=2 face="serif"> (Case No. 2:07-cv-10602, U.S. District Court, Newark, New Jersey), filed on April 5, 2007) was voluntarily withdrawn by the plaintiff. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The plaintiffs in each of the antitrust class action lawsuits seek monetary damages. All of the antitrust class action lawsuits have been consolidated for pre-trial purposes in a Multi-District Litigation (MDL) in federal
court in New Jersey.</FONT></P>

<P align="center">
<FONT size=2 face="serif">8</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<FONT size=2 face="serif">On June 6, 2006, UltiMed, Inc., a Minnesota company,
filed suit against the Company in the U.S. District Court in Minneapolis,
Minnesota (<I>UltiMed, Inc. v. Becton, Dickinson
and Company</I> (06CV2266)). The plaintiff alleges,
among other things, that the Company excluded the plaintiff from the market for
home use insulin syringes by entering into anticompetitive contracts in violation
of federal and state antitrust laws. The plaintiff seeks money damages and injunctive
relief. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">In June 2007, Retractable Technologies, Inc. (&#147;plaintiff&#148;)
filed a complaint against the Company under the caption </FONT><I><FONT size=2 face="serif">Retractable
Technologies, Inc. vs. Becton Dickinson and Company </FONT></I><FONT size=2 face="serif">(Civil
Action No. 2:07-cv-250, U.S. District Court, Eastern District of Texas).
Plaintiff alleges that the BD Integra&#153; syringes infringe patents licensed
exclusively to the plaintiff. This patent claim was not covered by the release
contained in the July 2004 settlement agreement between the Company and plaintiff
to settle the lawsuit previously filed by plaintiff. In its complaint, plaintiff
also alleges that the Company engaged in false advertising with respect to certain
of the Company&#146;s safety-engineered products in violation of the Lanham Act;
acted to exclude the plaintiff from various product markets and to maintain its
market share through, among other things, exclusionary contracts in violation
of state and federal antitrust laws; and engaged in unfair competition. The non-patent
claims purport to relate to actions allegedly taken by the Company following
the date of the July 2004 settlement agreement referenced above. In January 2008,
the court granted the Company&#146;s motion to sever the patent and non-patent
claims into separate cases. Plaintiff seeks treble damages, attorney&#146;s fees
and injunctive relief. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The Company, along with another manufacturer and several medical product distributors, is named as a defendant in three product liability lawsuits relating to healthcare workers who allegedly sustained accidental
needlesticks, but have not become infected with any disease. Generally, these actions allege that healthcare workers have sustained needlesticks using hollow-bore needle devices manufactured by the Company and, as a result, require medical testing,
counseling and/or treatment. In some cases, these actions additionally allege that the healthcare workers have sustained mental anguish. Plaintiffs seek money damages in all of these actions. The Company had previously been named as a defendant in
eight similar suits relating to healthcare workers who allegedly sustained accidental needlesticks, each of which has either been dismissed with prejudice or voluntarily withdrawn. Regarding the three pending suits: </FONT></P>
<UL>
<LI>
  <p align="justify"><FONT size=2 face="serif">In Ohio, <I>Grant vs. Becton Dickinson et al</I>. (Case No. 98CVB075616, Franklin County Court),
      on September 21, 2006, the Ohio Court of Appeals reversed the trial court&#146;s
      grant of class certification. The matter has been remanded to the trial court for a determination of whether the class can be
      redefined.</FONT></p>
</LI>

<LI>
  <p align="justify"><FONT size=2 face="serif">In Oklahoma and South Carolina, cases have been filed on
behalf of an unspecified number of healthcare workers seeking class action certification under the
laws of these states in state court in Oklahoma, under the caption <I>Palmer vs. Becton Dickinson et. al.</I>
(Case No. CJ-98-685, Sequoyah County District Court), filed on October 27, 1998, and in state court in South
Carolina, under the caption <I>Bales vs. Becton
    Dickinson et. al. </I>(Case No. 98-CP-40-4343, Richland County Court of Common Pleas), filed on November 25,
1998.</FONT></P>
</UL>
<P align="center">
<FONT size=2 face="serif">9</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<FONT size=2 face="serif">The Company continues to oppose class action certification in these cases, including pursuing all appropriate rights of appeal. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The Company, along with a number of other manufacturers, was named as a defendant in approximately 524 product liability lawsuits in various state and Federal courts related to natural rubber latex gloves which the Company
ceased manufacturing in 1995.  Cases pending in Federal court are being coordinated under the matter </FONT><I><FONT size=2 face="serif">In re Latex Gloves Products Liability Litigation</FONT></I><FONT size=2 face="serif"> (MDL Docket No. 1148) in
Philadelphia, and analogous procedures have been implemented in the state courts of California, Pennsylvania, New Jersey and New York. Generally, these actions allege that medical personnel have suffered allergic reactions ranging from skin
irritation to anaphylaxis as a result of exposure to medical gloves containing natural rubber latex. Since the inception of this litigation, 467 of these cases have been closed with no liability to the Company, and 46 cases have been settled for an
aggregate de minimis amount. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">On August 8, 2005, the Company received a subpoena issued by the Attorney General of the State of Connecticut, which seeks documents and information relating to the Company&#146;s participation as a member of Healthcare
Research &amp; Development Institute, LLC (&#147;HRDI&#148;), a healthcare trade organization. The subpoena indicated that it was issued as part of an investigation into possible violations of the antitrust laws. On August 21, 2006, the Company
received a subpoena issued by the Attorney General of the State of Illinois which sought documents and information relating to the Company&#146;s participation as a member of HRDI. The subpoena indicated that it was issued as part of an
investigation into possible violations of the Illinois Consumer Fraud and Deceptive Business Practices Act, Charitable Trust Act, and Solicitation for Charity Act. An independent member of the Company&#146;s board of directors, Gary Mecklenburg,
also served as a member and the non-executive chairman of HRDI until November 5, 2006. In January 2007, it was reported that HRDI entered into a settlement with the Attorneys General of Connecticut and Florida with respect to the investigation being
conducted by the Connecticut Attorney General (the Company has not been contacted by the State of Florida). To the Company&#146;s knowledge, both the Connecticut and Illinois investigations are still ongoing. The Company believes that its
participation in HRDI complied fully with the law and has responded to these subpoenas. The Company has not received any communication with respect to either investigation since completing its document production. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">On May 28, 2004, Therasense, Inc. (&#147;Therasense&#148;) filed suit against the Company in the U.S. District Court for the Northern District of California (Case Number: C 04-02123 WDB) asserting that the Company&#146;s
blood glucose monitoring products infringe certain Therasense patents. On August 10, 2004, in response to a motion filed by Therasense in the U.S. District Court for the District of Massachusetts, the court transferred to the court in California an
action previously filed by the Company against Therasense requesting a declaratory judgment that the Company&#146;s products do not infringe the Therasense patents and that the Therasense patents are invalid. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">As was previously reported, Becton Dickinson France, S.A., a subsidiary of the Company, was listed among approximately 2,200 other companies in an October 2005 report of the Independent Inquiry Committee (&#147;IIC&#148;)
of the United Nations (&#147;UN&#148;) as having been involved in humanitarian contracts in which unauthorized payments were suspected of having been made to the Iraqi Government in connection with the UN&#146;s Oil-for-Food Programme (the
&#147;Programme&#148;). The Company conducted an internal review and found no evidence that the Company or any employee or representative of the Company made, authorized, or approved improper payments to </FONT></P>
<P align="center">
<FONT size=2 face="serif">10</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<FONT size=2 face="serif">the Iraqi Government in connection with the Programme. The Company reported the results of its internal review to the Vendor Review Committee of the United Nations Procurement Service. In May 2007, the French Judicial
Police conducted searches of the Company&#146;s offices in France with respect to the matters that were the subject of the 2005 IIC report.  The Company was informed that it is one of a number of companies named in the IIC report that is being
investigated by the French Judicial Police.  The Company is cooperating fully with the investigation. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">In July 2007, the Company received notice of a suit
instituted in Saudi Arabia by El Seif Development (&#147;El Seif&#148;),
a former distributor of the Company (Case No. 7516, Board of Grievances, Saudi
Arabia). El Seif sought monetary damages arising out of the termination of its
distributor agreement and other contractual arrangements with the Company. This
matter has been settled on terms that are not material to the Company. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The Company has been served with a qui tam complaint filed by a private party against the Company in the United States District Court, Northern District of Texas, alleging violations of the Federal False Claims Act
(&#147;FCA&#148;) and the Texas False Claims Act (the &#147;TFCA&#148;). Under the FCA, the United States Department of Justice, Civil Division has a certain period of time in which to decide whether to join the claim against the Company as an
additional plaintiff; if not, the private plaintiff is free to pursue the claim on its own. A similar process is followed under the TFCA. To the Company's knowledge, no decision has yet been made by the Civil Division or the State of Texas whether
to join this claim. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The Company believes that it has meritorious defenses to each of the above-mentioned suits pending against the Company and is engaged in a vigorous defense of each of these matters.</FONT></P>
<P align="justify">
<FONT size=2 face="serif">The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The Company is a party to a number of Federal proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as &#147;Superfund,&#148; and similar state
laws. The affected sites are in varying stages of development. In some instances, the remedy has been completed, while in others, environmental studies are commencing. For all sites, there are other potentially responsible parties that may be
jointly or severally liable to pay all cleanup costs.</FONT></P>
<P align="justify">
<FONT size=2 face="serif">Given the uncertain nature of litigation generally, the Company is not able in all cases to estimate the amount or range of loss that could result from an unfavorable outcome of the litigation to which the Company is a
party.  In accordance with U.S. generally accepted accounting principles, the Company establishes accruals to the extent probable future losses are estimable (in the case of environmental matters, without considering possible third-party
recoveries). In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, excess liability insurance.  In the opinion of management, any such future
charges, individually or in the aggregate, could have a material adverse effect on the Company&#146;s consolidated results of operations and consolidated cash flows.</FONT></P>
<P align="center">
<FONT size=2 face="serif">11</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<U><FONT size=2 face="serif">Note 6 &#150; Segment Data</FONT></U><FONT size=2 face="serif"> </FONT><B><I><FONT size=2 face="serif"> </FONT></I></B></P>
<P align="justify">
<FONT size=2 face="serif">The Company&#146;s organizational structure is based upon its three principal business segments: BD Medical (&#147;Medical&#148;), BD Diagnostics (&#147;Diagnostics&#148;), and BD Biosciences (&#147;Biosciences&#148;). The
Company evaluates segment performance based upon operating income. Segment operating income represents revenues reduced by product costs and operating expenses.  Financial information for the Company&#146;s segments was as follows: </FONT></P>
<TABLE width="75%" border=0 cellpadding=0 cellspacing=0>
  <TR valign="bottom">
    <TD align=left nowrap></TD>
    <TD></TD>
    <TD align=center nowrap colspan=8><FONT size=2 face="serif">Three Months
        Ended</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap></TD>
    <TD></TD>
    <TD align=center nowrap colspan=8 style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">December
        31,</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2007</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2006</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><U><FONT size=2 face="serif">Revenues </FONT></U><FONT size=2 face="serif">(A)</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
    <TD width="8%" align=left nowrap>&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
    <TD width="8%" align=left nowrap>&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Medical</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">909,284</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">826,247</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Diagnostics</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">522,751</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">442,400</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Biosciences</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">273,732</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">232,879</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left valign="middle" nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">1,705,767</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left valign="middle" nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">1,501,526</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR>
    <TD colspan=10>&nbsp;</TD>
  </TR>
  <TR>
    <TD colspan=10>&nbsp;</TD>
  </TR>
  <TR>
    <TD colspan=10>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><U><FONT size=2 face="serif">Segment Operating Income</FONT></U></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Medical</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">262,408</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">246,143</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Diagnostics</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">126,926</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(345</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif"> (B)</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Biosciences</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">78,675</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">56,235</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Total
        Segment Operating Income</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">468,009</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">302,033</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Unallocated
        Items (C)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(101,437</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">(87,325</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">)</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Income
        from Continuing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Operations
        Before Income Taxes</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left valign="middle" nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">366,572</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left valign="middle" nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">214,708</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
</TABLE>
<BR>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
  <TR>
    <TD valign=top nowrap><I><FONT size=2 face="serif">(A)&nbsp;&nbsp;&nbsp;</FONT></I></TD>
    <TD valign="top"><I><FONT size=2 face="serif">Intersegment revenues are not
          material.</FONT></I></TD>
  </TR>
  <TR>
    <TD colspan=2 valign="top" nowrap><p><font size=1>&nbsp;</font></p>
    </TD>
  </TR>
  <TR>
    <TD valign=top nowrap><I><FONT size=2 face="serif">(B)&nbsp;&nbsp;&nbsp;</FONT></I></TD>
    <TD valign="top"><I><FONT size=2 face="serif">Includes the acquired in-process
          research and development charge of $114,739 recorded in 2007 related
          to the TriPath Imaging, Inc. acquisition.</FONT></I></TD>
  </TR>
  <TR>
    <TD colspan=2 valign="top" nowrap><p><font size=1>&nbsp;</font></p>
    </TD>
  </TR>
  <TR>
    <TD valign=top nowrap><I><FONT size=2 face="serif">(C)&nbsp;&nbsp;&nbsp;</FONT></I></TD>
    <TD valign="top"><I><FONT size=2 face="serif">Includes primarily share-based
          compensation expense; interest, net; foreign exchange; and corporate
          expenses.</FONT></I></TD>
  </TR>
  <TR>
    <TD colspan=2 nowrap>&nbsp;</TD>
  </TR>
</TABLE>
<P align="center">
<FONT size=2 face="serif">12</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>
<TABLE width="75%" border=0 cellpadding=0 cellspacing=0>
  <TR valign="bottom">
    <TD align=left nowrap></TD>
    <TD></TD>
    <TD align=center nowrap colspan=7><FONT size=2 face="serif">Three Months
        Ended</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap></TD>
    <TD></TD>
    <TD align=center nowrap colspan=7 style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">December
        31,</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2007</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2006</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><U><FONT size=2 face="serif">Revenues by Organizational
          Units</FONT></U></TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
    <TD width="8%" align=left nowrap>&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
    <TD width="8%" align=left nowrap>&nbsp;</TD>
    <TD width="1%" align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><U><FONT size=2 face="serif">BD Medical</FONT></U></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Medical
        Surgical Systems</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">498,811</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">467,751</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Diabetes
        Care</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">189,387</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">168,686</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Pharmaceutical
        Systems</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">201,941</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">172,940</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Ophthalmic
        Systems</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">19,145</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">16,870</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">909,284</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">826,247</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR>
    <TD colspan=9>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><U><FONT size=2 face="serif">BD Diagnostics</FONT></U></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Preanalytical
        Systems</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">271,469</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">240,072</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Diagnostic
        Systems</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">251,282</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">202,328</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">522,751</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">442,400</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><U><FONT size=2 face="serif">BD Biosciences</FONT></U></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Cell Analysis
        (A)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">205,113</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap><FONT size=2 face="serif">168,991</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Discovery
        Labware</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">68,619</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">63,888</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">273,732</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">232,879</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR>
    <TD colspan=9>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left valign="middle" nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">1,705,767</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left valign="middle" nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">1,501,526</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
</TABLE>
<BR>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR>
<TD nowrap valign=top>
<I><FONT size=2 face="serif">(A)&nbsp;&nbsp;&nbsp;</FONT></I></TD>
<TD valign="top">
<I><FONT size=2 face="serif">Cell Analysis consists of the Immunocytometry Systems and the Pharmingen organizational units that were previously reported separately.</FONT></I></TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR></TABLE>
<P align="center">
<FONT size=2 face="serif">13</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<U><FONT size=2 face="serif">Note 7 &#150; Share-Based Compensation</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The Company grants share-based awards under the 2004 Employee and Director Equity-Based Compensation Plan (the &#147;2004 Plan&#148;), which provides long-term incentive compensation to employees and directors. The Company
believes such awards align the interests of its employees and directors with those of its shareholders.</FONT></P>
<P align="justify">
<FONT size=2 face="serif">The fair value of share-based payments is recognized as compensation expense in net income. For the three months ended December 31, 2007 and 2006, compensation expense charged to income was $35,666 and $34,611,
respectively. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The amount of unrecognized compensation expense for all non-vested share-based awards as of December 31, 2007 was approximately $173,287, which is expected to be recognized over a weighted-average remaining life of
approximately 2.5 years. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The fair values of stock appreciation rights granted during the annual share-based grants in November of 2007 and 2006, respectively, were estimated on the date of grant using a lattice-based binomial valuation model based
on the following assumptions: risk-free interest rates of 3.83% and 4.56%, respectively; expected volatility of 27% and 28%, respectively; expected dividend yield of 1.35% and 1.37%, respectively; and expected life of 6.5 years for both
periods.</FONT><B><FONT size=2 face="serif"> </FONT></B></P>
<P align="justify">
<U><FONT size=2 face="serif">Note 8 &#150; Benefit Plans</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The Company has defined benefit pension plans covering substantially all of its employees in the United States and certain foreign locations. The Company also provides certain postretirement healthcare and life insurance
benefits to qualifying domestic retirees.  Other postretirement benefit plans in foreign countries are not material.</FONT></P>
<P align="justify">
<FONT size=2 face="serif">Net pension and postretirement cost included the following components for the three months ended December 31: </FONT></P>
<TABLE width="75%" border=0 cellpadding=0 cellspacing=0>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=center nowrap colspan=7 style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">Pension
        Plans</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=center nowrap colspan=7 style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">Other
        Postretirement Benefits</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2007</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2006</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2007</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2006</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Service cost</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD width="8%" align=right nowrap><FONT size=2 face="serif">16,570</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD width="8%" align=right nowrap><FONT size=2 face="serif">13,804</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD width="8%" align=right nowrap><FONT size=2 face="serif">1,155</FONT></TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD width="8%" align=right nowrap><FONT size=2 face="serif">1,088</FONT></TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Interest cost</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">20,436</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">15,124</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">3,723</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">3,644</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Expected return on plan assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(24,378</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(17,709</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">-</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">-</FONT></TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Amortization of prior service
        cost</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(285</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">39</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(1,558</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">(1,531</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">)</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Amortization of loss</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,995</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">3,449</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">987</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,166</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR>
    <TD colspan=17>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">14,338</FONT></TD>
    <TD width="1%" align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">14,707</FONT></TD>
    <TD width="1%" align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">4,307</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">4,367</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
</TABLE>
<BR>
<P align="justify">
<FONT size=2 face="serif">Postemployment benefit costs for the three months ended December 31, 2007 and 2006 were $5,941 and $6,028, respectively. </FONT></P>
<P align="center">
<FONT size=2 face="serif">14</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<U><FONT size=2 face="serif">Note 9 &#150; Divestiture</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">In December 2006, the Company sold the blood glucose monitoring product line for $19,971. The Company separately presents the results of the product line as discontinued operations.</FONT></P>
<P align="justify">
<FONT size=2 face="serif">Results of discontinued operations were as follows: </FONT></P>
<TABLE width="75%" border=0 cellpadding=0 cellspacing=0>
  <TR valign="bottom">
    <TD align=left nowrap></TD>
    <TD></TD>
    <TD align=center nowrap colspan=7><FONT size=2 face="serif">Three Months
        Ended</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap></TD>
    <TD></TD>
    <TD align=center nowrap colspan=7 style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">December
        31,</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2007</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">2006</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  </TR>
  <TR>
    <TD colspan=9>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Revenues</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD width="8%" align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">1,630</FONT></TD>
    <TD width="1%" align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%" align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD width="8%" align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">21,738</FONT></TD>
    <TD width="1%" align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR>
    <TD colspan=9>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Income from discontinued
        operations</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap>&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">before
        income taxes</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">1,038</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap><FONT size=2 face="serif">18,968</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=left nowrap><FONT size=2 face="serif">Income tax provision</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap>&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">386</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">7,140</FONT></TD>
    <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD align=left nowrap><FONT size=2 face="serif">Income from discontinued
        operations, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">652</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
    <TD width="5%">&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif">$</FONT></TD>
    <TD align=right nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">11,828</FONT></TD>
    <TD align=left nowrap style="border-bottom:3px double #000000;"><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
</TABLE>
<BR>
<P align="center">
<FONT size=2 face="serif">15</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<FONT size=2 face="serif">Item 2. </FONT><U><FONT size=2 face="serif">Management's Discussion and Analysis of Financial Condition and Results of Operations</FONT></U><FONT
size=2 face="serif"> </FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Company Overview</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">Becton, Dickinson and Company (&#147;BD&#148; or the &#147;Company&#148;) is a medical technology company engaged principally in the manufacture and sale of a broad range of medical supplies, devices, laboratory equipment
and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public. Our business consists of three worldwide business segments &#150; BD Medical (&#147;Medical&#148;), BD
Diagnostics (&#147;Diagnostics&#148;) and BD Biosciences (&#147;Biosciences&#148;). Our products are marketed in the United States and internationally through independent distribution channels, directly to end-users and by independent sales
representatives.</FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Financial Results</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">BD reported first quarter revenues of $1.706 billion, an increase of 14% from the same period a year ago, and reflected volume increases of approximately 9% and favorable foreign currency translation of approximately 6%,
and price decreases of less than 1%. Sales in the United States of safety-engineered devices grew 7% to $264 million in the first quarter of 2008, compared with the prior year&#146;s period. International sales of safety-engineered devices grew 24%
to $119 million in the first quarter of 2008, compared with the prior year&#146;s period.  Overall, international revenue growth of 17% for the three-month period included an 11% favorable impact of foreign currency translation.  As further
discussed in our 2007 Annual Report on Form 10-K, we face currency exposure that arises from translating the results of our worldwide operations to the U.S. dollar at exchange rates that fluctuate from the beginning of the period. We purchase option
and forward contracts to partially protect against adverse foreign exchange rate movements. </FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Recent Developments</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">BD purchases resins, which are oil-based components used in the manufacture of certain products. During the first quarter of 2008, we incurred higher resin purchase costs than the prior year&#146;s quarter, primarily due to
increases in world oil prices.  Such increases did not have a significant impact on our operating results for the quarter as we were able to offset them through productivity improvements and other cost reduction programs.  Any additional significant
increases in resin purchase costs could impact future operating results. </FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Results of Operations</FONT></U><B><FONT size=2 face="serif"> </FONT></B></P>
<P align="justify">
<U><FONT size=2 face="serif">Revenues</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">Refer to Note 6 in the Notes to Condensed Consolidated Financial Statements for segment financial data.</FONT></P>
<P align="justify">
<I><FONT size=2 face="serif">Medical Segment </FONT></I></P>
<P align="justify">
<FONT size=2 face="serif">First quarter revenues of $909 million represented an increase of $83 million, or 10%, from the prior year&#146;s quarter, including an estimated $47 million, or 6%, favorable impact due to foreign currency translation.
Pharmaceutical Systems and Diabetes Care products led revenue growth in </FONT></P>
<P align="center">
<FONT size=2 face="serif">16</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<FONT size=2 face="serif">the segment. Global sales of safety-engineered products were $187 million, as compared with $173 million in the prior year&#146;s quarter.</FONT></P>
<P align="justify">
<I><FONT size=2 face="serif">Diagnostics Segment</FONT></I><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">First quarter revenues of $523 million represented an increase of $80 million, or 18%, over the prior year&#146;s quarter, including an estimated $22 million, or 5%, favorable impact due to foreign currency translation and
5% attributable to TriPath, which was acquired in December 2006. The Preanalytical Systems unit of the segment reported revenue growth of 13% over the prior year&#146;s quarter. Global sales of safety-engineered products totaled $196 million,
compared with $169 million in the prior year&#146;s quarter due, in large part, to strong sales of BD Vacutainer&#174; Push Button Blood Collection Sets in the current year&#146;s quarter. Revenues in the Diagnostic Systems unit of the segment
increased 24% and reflect growth from molecular testing systems that include BD ProbeTec&#153;</FONT><I><FONT size=2 face="serif"> </FONT></I><FONT size=2 face="serif">ET and BD Viper&#153; instruments, as well as GeneOhm.  Incremental revenues from
TriPath of approximately $25 million also contributed to growth. </FONT></P>
<P align="justify">
<I><FONT size=2 face="serif">Biosciences Segment</FONT></I><B><I><FONT size=2 face="serif"> </FONT></I></B></P>
<P align="justify">
<FONT size=2 face="serif">First quarter revenues of $274 million represented an increase of $41 million, or 18%, over the prior year&#146;s quarter, including an estimated $15 million, or 6%, favorable impact due to foreign currency translation.
Research instruments, as well as clinical and research reagents, continued to be primary growth drivers.</FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Segment Operating Income</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<I><FONT size=2 face="serif">Medical Segment </FONT></I></P>
<P align="justify">
<FONT size=2 face="serif">Segment operating income for the first quarter was $262 million, or 28.9% of Medical revenues, compared with $246 million, or 29.8%, in the prior year&#146;s quarter.  Gross profit margin was lower than the first quarter of
2007 due to increased costs of raw materials, manufacturing startup costs, the unfavorable impact of foreign currency translation and decreased sales of products with higher margins.  See further discussion on gross profit margin below.  Selling and
administrative expense as a percent of Medical revenues in the first quarter of 2008 was significantly lower than the comparable amount in the first quarter of 2007, due to tight spending controls.  Research and development expenses for the quarter
increased $1.9 million, or 8%, reflecting increased investment in new products and platforms.</FONT></P>
<P align="justify">
<I><FONT size=2 face="serif">Diagnostics Segment </FONT></I></P>
<P align="justify">
<FONT size=2 face="serif">Segment operating income for the first quarter increased $127 million, which reflected the acquired in-process research and development charge of $115 million associated with the TriPath acquisition included in the prior
year&#146;s quarter.  Gross profit margin was lower than the first quarter of 2007.  Increased sales of products with relatively higher margins were more than offset by increased costs of raw materials and the unfavorable impact of foreign currency
translation.  See further discussion on gross profit margin below.  Selling and administrative expense as a percentage of Diagnostics revenues in the first quarter of 2008 was lower than the comparable amount in the first quarter of 2007, due to
tight spending controls. Research and development expenses in the first quarter of 2008 increased $8.1 million, or 34%, primarily due to investment in new products and incremental TriPath expenses.</FONT></P>
<P align="center">
<FONT size=2 face="serif">17</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<I><FONT size=2 face="serif">Biosciences Segment</FONT></I></P>
<P align="justify">
<FONT size=2 face="serif">Segment operating income for the first quarter was $79 million, or 28.7% of Biosciences revenues, compared with $56 million, or 24.1%, in the prior year&#146;s quarter. Gross profit margin as a percentage of revenues
increased due to improved production efficiencies, as well as increased sales of products with higher margins. See further discussion on gross profit margin below. Selling and administrative expense as a percent of Biosciences revenues for the
quarter decreased compared with the prior year&#146;s quarter, as a result of continued spending controls. Research and development spending in the quarter increased $1.5 million, or 8.4%, reflecting increased investment in new product
development.  </FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Gross Profit Margin</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">Gross profit margin was 51.4% for the first quarter,
compared with 52.8% for the comparable prior year period. Gross profit margin
in the first quarter of 2008 as compared with the prior year&#146;s period reflected
an estimated 0.7% unfavorable impact of foreign currency translation and an estimated
0.4% of increased resin and steel costs, as well as manufacturing start-up costs.
Increased sales of products with relatively higher margins and productivity gains
were more than offset by, among other things, asset write-offs, resulting in
an estimated net unfavorable impact of 0.3%. We expect gross profit margin to
decrease by about 20 basis points in 2008. Increased resin and steel costs as
well as manufacturing start-up costs in 2008 are anticipated to offset expected
improvements. </FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Selling and Administrative Expense</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">Selling and administrative expense was 24.7% of revenues for the first quarter, compared with 25.6% for the prior year&#146;s period. Aggregate expenses for the current period reflect increases in base spending of $11
million and in expenses associated with TriPath operations of $8 million, as well as an unfavorable foreign exchange impact of $19 million. Selling and administrative expense as a percentage of revenues is expected to decrease by about 70 basis
points in 2008.</FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Research and Development Expense</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">Research and development expense of $92 million for the first quarter increased 14%, compared with the prior year&#146;s amount of $80 million.  The increase in research and development expenditures reflect increased
spending for new programs in each of our segments for the three-month period ended 2008.  We anticipate Research and development expense to increase by about 11% for 2008.</FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Non-Operating Expense and Income</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">Interest income was $14 million in the first quarter, compared with $16 million in the prior year&#146;s period, resulting from lower cash balances. Interest expense was $10 million in the first quarter, compared with $13
million in the prior year&#146;s period, which reflects lower debt and higher levels of capitalized interest. </FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Income Taxes</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The income tax rate was 26.1% for the first quarter, compared with the prior year&#146;s rate of 39.0% . The prior year&#146;s rate reflected the non-deductibility of the acquired in-process research and development charges
associated with the TriPath acquisition, which was partially offset by the impact of approximately 2.0% resulting from the retroactive reinstatement of the research and experimentation tax credit.  The Company expects the reported tax rate for 2008
to be slightly above 27%.</FONT></P>
<P align="center">
<FONT size=2 face="serif">18</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<U><FONT size=2 face="serif">Income from Continuing Operations and Diluted Earnings Per Share from Continuing Operations</FONT></U></p>
<P align="justify">
<FONT size=2 face="serif">Income from
continuing operations and diluted earnings per share from continuing operations for the first quarter of 2008 were $271 million and $1.07, respectively.  Income from continuing operations and diluted earnings per share from continuing operations for
the prior year&#146;s first quarter were $131 million and 51 cents, respectively.  The prior year&#146;s period reflected the acquired in-process research and development charge associated with the TriPath acquisition of $115 million or 45 cents per
share. </FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Liquidity and Capital Resources</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">Net cash provided by continuing operating activities, which continues to be our primary source of funds to finance operating needs and capital expenditures, was $473 million during the first quarter of 2008, compared with
$276 million in the same period in 2007. Net cash provided by continuing operations in the first quarters of the current and prior year was reduced by changes in the pension obligation, resulting primarily from discretionary cash contributions of
approximately $23 million and $75 million, respectively.</FONT><FONT size=2 face="sans-serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">Net cash used for continuing investing activities for the first quarter of the current year was $139 million, compared with $450 million in the prior year period. The prior year amount reflects the payment of $340 million
of net cash for the TriPath acquisition. Capital expenditures were $121 million in the first three months of 2008 and $111 million in the same period in 2007. We expect capital spending for 2008 to be about $650 million.</FONT></P>
<P align="justify">
<FONT size=2 face="serif">Net cash used for continuing financing activities for the first quarter of the current year was $101 million, compared with $306 million in the prior year period. As of December 31, 2007, total debt of $1.2 billion
represented 20.4% of total capital (shareholders' equity, net non-current deferred income tax liabilities, and debt), versus 20.9% at September 30, 2007. Short-term debt was 18% of total debt at the end of December 31, 2007 and September 30, 2007,
respectively. Issuance of common stock is net of cash outflows resulting from share repurchases to satisfy minimum tax withholding on share-based compensation vested or exercised. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">For the first quarter of the current year, the Company repurchased $123 million of its common stock, compared with approximately $112 million of its common stock in the prior year period. At December 31,
2007, authorization to repurchase an additional 9.6 million common shares remained.</FONT></P>
<P align="justify">
<FONT size=2 face="serif">We have in place a commercial paper borrowing program that is available to meet our short-term financing needs, including working capital requirements.  Borrowings outstanding under this program were $200
million at December 31, 2007. During the first quarter of 2008, we amended our syndicated credit facility to extend the expiration date from December 2011 to December 2012. This credit facility, under which there were no borrowings outstanding at
December 31, 2007, provides backup support for our commercial paper program and can also be used for other general corporate purposes. This credit facility includes a single financial covenant that requires BD to maintain an interest expense
coverage ratio (ratio of earnings before income taxes, depreciation and amortization to interest expense) of not less than 5-to-1 for the most recent four consecutive fiscal quarters. On the last eight measurement dates, this ratio has ranged from
17-to-1 to 26-to-1. In addition, we have informal lines of credit outside the United States.</FONT></P>
<P align="center">
<FONT size=2 face="serif">19</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<U><FONT size=2 face="serif">Contractual Obligations</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The contractual obligations table as of September 30, 2007, included in the &#147;Financial Review&#148; section of our 2007 Annual Report, did not reflect amounts associated with uncertain tax positions. As a result of the
adoption on October 1, 2007 of Financial Accounting Standards Board (&#147;FASB&#148;) Interpretation No. 48 (&#147;FIN 48&#148;), &#147;Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109&#148; (see Note 2 to the
Condensed Consolidated Financial Statements), our year-end disclosure of contractual obligations will now include information concerning uncertain tax positions. As of December 31, 2007, there have been no significant changes in our contractual
obligations.</FONT></P>
<P align="justify">
<U><FONT size=2 face="serif">Cautionary Statement Regarding Forward-Looking Statements</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">BD and its representatives may from time-to-time make certain forward-looking statements in publicly released material, both written and oral, including statements contained in this report and filings with the Securities
and Exchange Commission (&#147;SEC&#148;) and in our other reports to shareholders. Forward-looking statements may be identified by the use of words like &#147;plan,&#148; &#147;expect,&#148; &#147;believe,&#148; &#147;intend,&#148;
&#147;will,&#148; &#147;anticipate,&#148; &#147;estimate&#148; and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance, as well as our strategy for growth, product
development, regulatory approvals, market position and expenditures. All statements that address operating performance or events or developments that we expect or anticipate will occur in the future -- including statements relating to volume growth,
sales and earnings per share growth, and statements expressing views about future operating results -- are forward-looking. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">Forward-looking statements are based on current expectations of future events. The forward-looking statements, are and will be, based on management's then-current views and assumptions regarding future events and operating
performance, and speak only as of their dates. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections.
Investors are therefore cautioned not to place undue reliance on any forward-looking statements. Furthermore, we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events and
developments or otherwise. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">The following are some important factors that could cause our actual results to differ from our expectations in any forward-looking statements: </FONT></P>
<UL>
<LI>
  <p align="justify"><FONT size=2 face="serif">Regional, national and foreign economic factors, including inflation
and fluctuations in interest rates and foreign currency exchange rates, and the potential effect of such fluctuations
on revenues, expenses and resulting margins, as well as on competition in certain
markets.</FONT></p>
</LI>

<LI>
  <p align="justify"><FONT size=2 face="serif">Fluctuations in the cost and availability of oil-based resins and other raw materials and the ability to maintain favorable supplier arrangements and relationships (particularly with respect to sole-source suppliers) and the potential adverse effects of any disruption in the availability of such raw materials.</FONT></p>
</LI>

<LI>
  <p align="justify"><FONT size=2 face="serif">We operate in a highly competitive environment. New product introductions by our current or future competitors (for example, new forms of drug delivery) could adversely affect our ability to compete in the global market. Patents attained by competitors, particularly as patents on our products expire, may also adversely impact our competitive position. Certain competitors have established manufacturing sites or have contracted with
suppliers in low- cost manufacturing locations as a means to lower their costs.
New entrants may also
appear.</FONT></p>
</LI>
</UL>
<P align="center">
<FONT size=2 face="serif">20</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><p>


<UL>
<LI><p align="justify">
  <FONT size=2 face="serif">Changes in domestic and foreign healthcare industry practices and regulations
resulting in increased pricing pressures, including the continued consolidation among healthcare providers; trends toward
managed care and healthcare cost containment; and government laws and regulations relating to sales and promotion,
reimbursement and pricing generally.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">The effects, if any, of governmental and media activities regarding the
business practices of group purchasing organizations, which negotiate product prices on behalf of their member hospitals
with BD and other suppliers.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">Our ability to obtain the anticipated benefits of any restructuring programs, if any, that we may undertake.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">Adoption of, or changes, in government laws and regulations affecting domestic and foreign operations, including those relating to trade, monetary and fiscal policies, taxation, environmental matters, sales practices, price controls, licensing and regulatory approval of new products, regulatory requirements for products in the postmarketing phase, or changes in enforcement practices with respect to any such laws and regulations. In particular, environmental laws, particularly with respect to the emission of greenhouse gases, are becoming more stringent throughout the world, which may increase our costs of operations or necessitate changes in our manufacturing plants or processes.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">Fluctuations in U.S. and international governmental funding and policies for life science research.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">Difficulties inherent in product development, including the potential inability to successfully continue technological innovation, complete clinical trials, obtain regulatory approvals in
the United States and abroad, obtain coverage and adequate reimbursement for new products, or gain and maintain market approval of products, as well as the possibility of
encountering infringement claims by competitors with respect to patent or other intellectual property rights, all of which can preclude or delay commercialization of a
product.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">Pending and potential litigation or other proceedings adverse to BD, including antitrust claims, product liability claims, and patent infringement claims and the availability or collectibility of insurance.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">The effects, if any, of adverse media exposure or other publicity regarding BD&#146;s business or operations.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">Our ability to achieve earnings forecasts, which are generated based on projected volumes and sales of many product types, some of which are more profitable than others. There can be no assurance that we will achieve the projected level or mix of product sales.</FONT></p>
</LI>
</UL>
<P align="center">
<FONT size=2 face="serif">21</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><p>


<UL>
<LI>
  <p align="justify"><FONT size=2 face="serif">The effect of market fluctuations on the value of assets in BD&#146;s pension plans and the possibility that BD may need to make additional contributions to the plans as a result of
any decline in the value of such assets.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">Our ability to effect infrastructure enhancements and incorporate new systems technologies into our operations.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">Product efficacy or safety concerns resulting in product recalls, regulatory action on the part of the U.S. Food and Drug Administration (or foreign counterparts) or declining
sales.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">Economic and political conditions in international markets, including civil unrest, terrorist activity, governmental changes, restrictions on the ability to transfer capital across
borders and expropriation of assets by a government.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">The effects of natural disasters, including hurricanes or pandemic diseases, on our ability to manufacture our products, particularly where production of a product line is concentrated
in one or more plants, or on our ability to source components from suppliers that are needed for such manufacturing.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">Our ability to penetrate developing and emerging markets, which also depends on economic and political conditions, and how well we are able to acquire or form strategic business alliances with local companies and make necessary infrastructure enhancements to production facilities, distribution networks, sales equipment and technology.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">The impact of business combinations, including acquisitions and divestitures, both internally on BD and externally on the healthcare industry.</FONT></p>
</LI>
<LI>
  <p align="justify"><FONT size=2 face="serif">Issuance of new or revised accounting standards by the Financial Accounting Standards Board or the SEC.</FONT></p>
</LI>
</UL>
<P align="justify">
<FONT size=2 face="serif">The foregoing list sets forth many, but not all, of the factors that could impact our ability to achieve results described in any forward-looking statements. Investors should understand that it is not possible to predict or
identify all such factors and should not consider this list to be a complete statement of all potential risks and uncertainties.</FONT></P>
<P align="center">
<FONT size=2 face="serif">22</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<FONT size=2 face="serif">Item 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U><FONT size=2 face="serif">Quantitative and Qualitative Disclosures About Market Risk</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">There have been no material changes in information reported since the end of the fiscal year ended September 30, 2007. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">Item 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U><FONT size=2 face="serif">Controls and Procedures</FONT></U><FONT size=2 face="serif"> </FONT></P>
<P align="justify">
<FONT size=2 face="serif">An evaluation was carried out by BD&#146;s management,
with the participation of our Chief Executive Officer and Chief Financial Officer,
of the effectiveness of the design and operation of BD&#146;s
disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities
Exchange Act of 1934) as of December 31, 2007. Based upon that evaluation, the
Chief Executive Officer and Chief Financial Officer concluded that the design
and operation of these disclosure controls and procedures were, as of the end
of the period covered by this report, effective. There were no changes in our
internal control over financial reporting during the fiscal quarter ended December
31, 2007 that have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting. </FONT></P>
<P align="center">
<FONT size=2 face="serif">23</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="justify">
<FONT size=2 face="serif">PART II - OTHER INFORMATION</FONT></P>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="10%" valign="top"><FONT size=2 face="serif">Item 1.</FONT></td>
    <td valign="top"><P align="justify"><U><FONT size=2 face="serif">Legal Proceedings</FONT></U><FONT size=2 face="serif"> </FONT></P>
      <P align="justify"> <FONT size=2 face="serif">We are involved, both as
          a plaintiff and a defendant, in various legal proceedings which arise
          in the ordinary course of business, including product liability and
          environmental matters as set forth in our 2007 Annual Report on Form
          10-K. </FONT></P>
      <P align="justify"> <FONT size=2 face="serif">Since September 30, 2007,
          the following developments have occurred with respect to the legal
          proceedings in which we are involved:</FONT></P>
      <P align="justify"> <FONT size=2 face="serif">In July 2007, BD received
          notice of a suit instituted in Saudi Arabia by El Seif Development
          (&#147;El Seif&#148;), a former BD distributor (Case No. 7516, Board
          of Grievances, Saudi Arabia). El Seif sought monetary damages arising
          out of the termination of its distributor agreement and other contractual
          arrangements with BD. This matter has been settled on terms that are
          not material to BD. </FONT></P>
      <P align="justify"> <FONT size=2 face="serif">In January 2008, the court
          in </FONT><U><FONT size=2 face="serif">Retractable Technologies, Inc.
          vs. Becton Dickinson and
          Company</FONT></U><FONT
size=2 face="serif"> (Civil Action No. 2:07-cv-250, U.S. District Court, Eastern
          District of Texas) granted BD&#146;s motion to sever the plaintiff&#146;s
          patent and non-patent claims into separate cases. </FONT></P>
      <P align="justify"> <U><FONT size=2 face="serif">Summary</FONT></U><FONT size=2 face="serif"> </FONT></P>
      <P align="justify"> <FONT size=2 face="serif">Given the uncertain nature
          of litigation generally, BD is not able in all cases to estimate the
          amount or range of loss that could result from an unfavorable outcome
          of the litigation to which BD is a party. In accordance with U.S. generally
          accepted accounting principles, BD establishes accruals to the extent
          probable future losses are estimable (in the case of environmental
          matters, without considering possible third-party recoveries). In view
          of the uncertainties of litigation, BD could incur charges in excess
          of any currently established accruals and, to the extent available,
          excess liability insurance. In the opinion of management, any such
          future charges, individually or in the aggregate, could have a material
          adverse effect on BD&#146;s consolidated results of operations and
    consolidated cash flows.</FONT></P></td>
  </tr>
</table>

<P align="center">
<FONT size=2 face="serif">24</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
  <TR valign="bottom">
    <TD width=10% align=left nowrap><FONT size=2 face="serif">Item 1A.</FONT></TD>
    <TD align=left><U><FONT size=2 face="serif">Risk Factors</FONT></U></TD>
  </TR>
  <TR valign="bottom">
    <TD width="10%" align=left nowrap>&nbsp;</TD>
    <TD align=left>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD width=10% align=left nowrap>&nbsp;</TD>
    <TD align=left><FONT size=2 face="serif">There have been no material changes
        from the risk factors disclosed in Part 1, Item 1A, of our Annual Report
        on Form 10-K for the 2007 fiscal year.</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD align=center colspan=2><FONT size=2 face="serif">&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD width=10% align=left nowrap><FONT size=2 face="serif">Item 2.</FONT></TD>
    <TD align=left><U><FONT size=2 face="serif">Unregistered Sales of Equity
          Securities and Use of Proceeds</FONT></U></TD>
  </TR>
  <TR valign="bottom">
    <TD width="10%" align=left nowrap>&nbsp;</TD>
    <TD align=left>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD width=10% align=left nowrap>&nbsp;</TD>
    <TD align=justify><FONT size=2 face="serif">The table below sets forth certain
        information regarding our purchases of common stock of BD during the
        quarter ended December 31, 2007.</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD width=10% align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif"></FONT></TD>
  </TR>
</TABLE>
<BR>
<P align="center">
<U><FONT size=2 face="serif">Issuer Purchases of Equity Securities</FONT></U><FONT size=2 face="serif"> </FONT></P>
<TABLE width="100%" style="border:1px solid #000000" cellpadding=5 cellspacing=0>
  <TR valign="bottom">
    <TD width="28%" align=left nowrap><FONT size=2 face="serif">For the three
        months ended <br>
        December 31, 2007</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">Total Number of<br>
       Shares Purchased <br>
        (1)</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">Average Price<br>
       Paid per<br>
       Share</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">Total Number of<br>
       Shares Purchased <br>
        as Part of<br>
         Publicly<br>
           Announced Plans <br>
            or Programs (2)</FONT></TD>
    <TD align=left nowrap><FONT size=2 face="serif">Maximum Number<br>
       of Shares that May<br>
         Yet Be Purchased <br>
          Under the Plans or<br>
           Programs (2)</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD width="28%" align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">October
        1 &#150; 31, 2007</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,659&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">$82.51</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">11,111,814&nbsp;&nbsp;&nbsp;</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD width="28%" align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">November
        1 &#150; 30, 2007</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,502,704&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">$81.83</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,500,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">9,611,814</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD width="28%" align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">December
        1 &#150; 31, 2007</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">13,012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">$83.23</FONT></TD>
    <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">9,611,814</FONT></TD>
  </TR>
  <TR valign="bottom" bgcolor="#E5FFFF">
    <TD width="28%" align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">Total</FONT></TD>
    <TD width="18%" align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,517,375&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="18%" align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">$81.85</FONT></TD>
    <TD width="18%" align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">1,500,000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="18%" align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">9,611,814</FONT></TD>
  </TR>
</TABLE>
<BR>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR>
  <TD width="10%" valign=top nowrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
<TD width="5%" valign=top nowrap>
<FONT size=2 face="serif">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD width=85% valign="top">
      <p align="justify"><FONT size=2 face="serif">Includes 3,015 shares purchased
          during the quarter in open market transactions by the trustee under
          BD&#146;s Deferred Compensation Plan and 1996 Directors&#146; Deferral
          Plan, and 14,360 shares delivered to BD in connection with stock option
    exercises.</FONT></p></TD>
</TR>
<TR><TD colspan=3 valign="top">&nbsp;</TD>
</TR><TR>
<TD width="10%" valign=top nowrap>&nbsp;</TD>
<TD width="5%" valign=top nowrap>
<FONT size=2 face="serif">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD width=85% valign="top">
      <p align="justify"><FONT size=2 face="serif">Repurchases of 1,111,814
          were made pursuant to a repurchase program for 10 million shares announced
          on November 22, 2005. The remaining repurchases of were made pursuant
          to a repurchase program covering 10 million shares authorized by the
          Board of Directors of BD (the &#147;Board&#148;) on July 24, 2007 (the &#147;2007 Program&#148;).
    There is no expiration date for the 2007 Program.</FONT></p></TD>
</TR>
<TR><TD colspan=3>&nbsp;</TD></TR></TABLE>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
  <TR valign="bottom">
    <TD width="10%" align=left nowrap><FONT size=2 face="serif">Item 3.</FONT></TD>
    <TD align=left><U><FONT size=2 face="serif">Defaults Upon Senior Securities</FONT></U></TD>
  </TR>
  <TR valign="bottom">
    <TD width="10%" align=left nowrap>&nbsp;</TD>
    <TD align=left>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD width="10%" align=left nowrap>&nbsp;</TD>
    <TD align=left><FONT size=2 face="serif">Not applicable.</FONT></TD>
  </TR>
  <TR>
    <TD colspan=2>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD width="10%" align=left nowrap><FONT size=2 face="serif">Item 4.</FONT></TD>
    <TD align=left><U><FONT size=2 face="serif">Submission of Matters to a Vote
          of Security Holders</FONT></U></TD>
  </TR>
  <TR valign="bottom">
    <TD width="10%" align=left nowrap>&nbsp;</TD>
    <TD align=left>&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD width="10%" align=left nowrap>&nbsp;</TD>
    <TD align=left><FONT size=2 face="serif">There were no matters submitted
        to a vote of security holders during the fiscal quarter ended December
        31, 2007.</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD width="10%" align=left nowrap>&nbsp;</TD>
    <TD align=left><FONT size=2 face="serif"></FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD width="10%" align=left nowrap>&nbsp;</TD>
    <TD align=left><FONT size=2 face="serif">Our Annual Meeting of Shareholders
        was held on January 29, 2008, at which the following matters were voted
        upon:</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD width="10%" align=left nowrap>&nbsp;</TD>
    <TD align=left nowrap><FONT size=2 face="serif"></FONT></TD>
  </TR>
</TABLE>
<BR>
<P align="center">
<FONT size=2 face="serif">25</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR>
  <TD width="10%" valign=top nowrap>&nbsp;</TD>
<TD align=right width="5%" valign=top nowrap>
<FONT size=2 face="serif">i.)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD>
<FONT size=2 face="serif">A management proposal for the election of five directors for the terms indicated below was voted upon as follows:</FONT></TD>
</TR>
<TR><TD colspan=3>&nbsp;</TD></TR></TABLE>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD width=15% rowspan="7" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD  width=1%>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD colspan="3" align=center nowrap><FONT size=2 face="serif">&nbsp; </FONT><U><FONT size=2 face="serif">Votes</FONT></U></TD>
  <TD align=center nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=20% align=left nowrap>
<U><FONT size=2 face="serif">Nominee</FONT></U></TD>
<TD>&nbsp;</TD>
<TD width=20% align=left nowrap>
<U><FONT size=2 face="serif">Term</FONT></U></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<U><FONT size=2 face="serif">For Votes</FONT></U></TD>
<TD width="1%">&nbsp;</TD>
<TD align=right nowrap>
<U><FONT size=2 face="serif">Withheld</FONT></U></TD>
    <TD width="15%" rowspan="6" align=right nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Basil L. Anderson</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">3 Years</FONT></TD>
<TD>&nbsp;</TD>
<TD width="12%" align=left nowrap>
<FONT size=2 face="serif">217,003,936</FONT></TD>
<TD>&nbsp;</TD>
<TD width="12%" align=right nowrap>
<FONT size=2 face="serif">4,546,941</FONT></TD>
  </TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Marshall O. Larsen</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">3 Years</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">216,687,878</FONT></TD>
<TD>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">4,862,999</FONT></TD>
  </TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Gary A. Mecklenburg</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">3 Years</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">217,243,382</FONT></TD>
<TD>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">4,307,495</FONT></TD>
  </TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Cathy E. Minehan</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">3 Years</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">167,485,929</FONT></TD>
<TD>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">54,064,948</FONT></TD>
  </TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Alfred Sommer</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">3 Years</FONT></TD>
<TD>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">190,608,193</FONT></TD>
<TD>&nbsp;</TD>
<TD align=right nowrap>
<FONT size=2 face="serif">30,942,684</FONT></TD>
  </TR>
</TABLE>
<BR>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR>
  <TD width="10%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
<TD width="5%">&nbsp;</TD>

<TD width=85%>
<p align=justify>
<FONT size=2 face="serif">The directors whose term of office as a director continued after the meeting are: Henry P. Becton, Jr., Edward F. DeGraan, Claire M. Fraser-Liggett, Edward J. Ludwig, Adel A.F. Mahmoud, James F. Orr, Willard J. Overlock,
Jr. and Bertram L. Scott.</FONT></p></TD>
</TR>
<TR><TD colspan=3>&nbsp;</TD></TR><TR>
  <TD width="10%" valign=top nowrap>&nbsp;</TD>
<TD align=right width="5%" valign=top nowrap>
<FONT size=2 face="serif">ii.)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>

<TD width=85%>
<p align=justify>
<FONT size=2 face="serif"> A management proposal to ratify the selection of Ernst &amp; Young, LLP as independent registered public accounting firm for the fiscal year ending September 30, 2008 was voted upon. 217,209,892 shares were voted for the
proposal, 2,534,609 shares were voted against, and 1,806,376 shares abstained.</FONT></p></TD>
</TR>
<TR><TD colspan=3>&nbsp;</TD></TR><TR>
  <TD width="10%" valign=top nowrap>&nbsp;</TD>
<TD align=right width="5%" valign=top nowrap>
<FONT size=2 face="serif">iii.)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>

<TD width=85%>
<p align=justify>
<FONT size=2 face="serif"> A shareholder proposal requesting that the Board of Directors take the necessary steps to
provide for the annual election of directors was voted upon.
165,660,344 shares were voted for the proposal, 33,089,524 shares were voted against,
2,561,047 shares abstained, and there were 20,239,961 broker non-votes.</FONT></p></TD>
</TR>

<TR><TD colspan=3>&nbsp;</TD></TR><TR>
  <TD width="10%" valign=top nowrap>&nbsp;</TD>
<TD align=right width="5%" valign=top nowrap>
<FONT size=2 face="serif">iv.)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>

<TD width=85%>
<p align=justify>
<FONT size=2 face="serif"> A shareholder proposal requesting that the Board of Directors take the necessary steps to provide for cumulative voting in the election of directors was voted upon. 71,175,797 shares were voted for the proposal,
127,873,513 shares were voted against, 2,261,605 shares abstained, and there were 20,239,961 broker non-votes.</FONT></p></TD>
</TR>
<TR><TD colspan=3>&nbsp;</TD></TR><TR>
  <TD width="10%" valign=top nowrap>&nbsp;</TD>
<TD align=right width="5%" valign=top nowrap>
<FONT size=2 face="serif">v.)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>

<TD width=85%>
<p align=justify>
<FONT size=2 face="serif"> A shareholder proposal requesting that the Company provide an environmental report was voted upon. 53,282,419 shares were voted for the proposal, 94,125,388 shares were voted against, 53,903,109 shares abstained, and
there were 20,239,961 broker non-votes.</FONT></p></TD>
</TR>
<TR><TD colspan=3>&nbsp;</TD></TR></TABLE>
<P align="center">
<FONT size=2 face="serif">26</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
<TD width="10%" align=left nowrap>
<FONT size=2 face="serif">Item 5.</FONT></TD>
<TD align=left nowrap>
<U><FONT size=2 face="serif">Other Information</FONT></U></TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width="10%" align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Not applicable.</FONT></TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width="10%" align=left nowrap>
<FONT size=2 face="serif">Item 6.</FONT></TD>
<TD align=left nowrap>
<U><FONT size=2 face="serif">Exhibits</FONT></U></TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
  <TR valign="bottom">
    <TD width="12%" align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top" nowrap><FONT size=2 face="serif">Exhibit 10(d)(i)</FONT></TD>
    <TD align=left valign="top"><FONT size=2 face="serif">Deferred Compensation
        Plan, as amended and restated as of December 31, 2007.</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD width="12%" align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top"><FONT size=2 face="serif"></FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD width="12%" align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top" nowrap><FONT size=2 face="serif">Exhibit 10(d)(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD align=left valign="top"><FONT size=2 face="serif">1996 Directors&#146; Deferral
        Plan, as amended and restated as of December 31, 2007.</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD width="12%" align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top"><FONT size=2 face="serif"></FONT></TD>
  </TR>

 <TR valign="bottom">
    <TD width="12%" align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top" nowrap><FONT size=2 face="serif">Exhibit 10(r)</FONT></TD>
    <TD align=left valign="top"><FONT size=2 face="serif">Amended and Restated Five-Year Credit Agreement, dated as of December 1, 2006 among the registrant and the banks named therein.</FONT></TD>
  </TR> <TR valign="bottom">
    <TD width="12%" align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
    <TD width="12%" align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top" nowrap><FONT size=2 face="serif">Exhibit 31</FONT></TD>
    <TD align=left valign="top"><FONT size=2 face="serif">Certifications of Chief
        Executive Officer and Chief Financial Officer, pursuant to SEC Rule 13a
        - 14(a).</FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD width="12%" align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top"><FONT size=2 face="serif"></FONT></TD>
  </TR>
  <TR valign="bottom">
    <TD width="12%" align=left valign="top" nowrap>&nbsp;</TD>
    <TD align=left valign="top" nowrap><FONT size=2 face="serif">Exhibit 32</FONT></TD>
    <TD align=left valign="top"><FONT size=2 face="serif">Certifications of Chief
        Executive Officer and Chief Financial Officer,
        pursuant to Rule 13a - 14(b) and Section 1350 of Chapter 63
        of Title 18 of the U.S. Code.</FONT></TD>
  </TR>
</TABLE>
<BR>
<P align="center">
<FONT size=2 face="serif">27</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="center">
<FONT size=2 face="serif">SIGNATURES </FONT></P>
<P align="justify">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
<TD width="49%" align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;&nbsp;&nbsp;&nbsp;<U><FONT size=2 face="serif">Becton, Dickinson and Company</FONT></U></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD width="49%" align=left nowrap>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">(Registrant)</FONT></TD>
</TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>
<FONT size=2 face="serif">Dated:&nbsp;&nbsp;&nbsp;February 4, 2008</FONT></TD>
<TD align=left nowrap>
<FONT size=2 face="serif"></FONT></TD>
<TD align=left nowrap>&nbsp;</TD>
</TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>
<U><FONT size=2 face="serif">/s/ John R. Considine&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></U></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">John R. Considine</FONT></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Senior Executive Vice President and</FONT></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Chief Financial Officer</FONT></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">(Principal Financial Officer)</FONT></TD>
</TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>
<U><FONT size=2 face="serif">/s/ William A. Tozzi&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></U></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">William A. Tozzi</FONT></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">Vice President - Finance</FONT></TD>
</TR>
<TR valign="bottom">
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif">(Chief Accounting Officer)</FONT></TD>
</TR>
</TABLE>
<BR>
<P align="center">
<FONT size=2 face="serif">28</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE><br>


<P align="center">
<FONT size=2 face="serif">INDEX TO EXHIBITS </FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
<TD width="10%" align=left nowrap>
<U><FONT size=2 face="serif">Exhibit Number</FONT></U></TD>
<TD width="3%">&nbsp;</TD>
<TD align=left nowrap>
<U><FONT size=2 face="serif">Description of Exhibits</FONT></U></TD>
</TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width="10%" nowrap>
<FONT size=2 face="serif">10(d)(i)</FONT></TD>
<TD width="3%">&nbsp;</TD>
<TD align=left>
<FONT size=2 face="serif">Deferred Compensation Plan, as amended and restated as of December 31, 2007</FONT></TD>
</TR>
<TR valign="bottom">
<TD width="10%" align=left nowrap>&nbsp;</TD>
<TD width="3%">&nbsp;</TD>
<TD align=right nowrap>&nbsp;</TD>
  </TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width="10%" nowrap>
<FONT size=2 face="serif">10(d)(ii)</FONT></TD>
<TD width="3%">&nbsp;</TD>
<TD align=left>
<FONT size=2 face="serif">1996 Directors&#146; Deferral Plan, as amended and restated as of December 31, 2007</FONT></TD>
</TR>
<TR valign="bottom">
<TD width="10%" align=left nowrap>&nbsp;</TD>
<TD width="3%">&nbsp;</TD>
<TD align=right nowrap>&nbsp;</TD>
  </TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>

<TR valign="bottom">
<TD width="10%" nowrap>
<FONT size=2 face="serif">10(r)</FONT></TD>
<TD width="3%">&nbsp;</TD>
<TD align=left><font size="2" face="serif">Amended and Restated Five-Year Credit Agreement, dated as of December 1, 2006 among the registrant and the banks named therein.</font></TD>
</TR>
<TR valign="bottom">
<TD width="10%" nowrap>
<FONT size=2 face="serif"></FONT></TD>
<TD width="3%">&nbsp;</TD>
<TD align=left><font size="2" face="serif"></font></TD>
</TR>
<TR valign="bottom">
<TD width="10%" align=left nowrap>&nbsp;</TD>
<TD width="3%">&nbsp;</TD>

<TR valign="bottom">
<TD width="10%" nowrap>
<FONT size=2 face="serif">31</FONT></TD>
<TD width="3%">&nbsp;</TD>
<TD align=left>
<FONT size=2 face="serif">Certifications of Chief Executive Officer and Chief Financial Officer,
pursuant to SEC Rule 13a - 14(a).</FONT></TD>
</TR>
<TR valign="bottom">
<TD width="10%" align=left nowrap>&nbsp;</TD>
<TD width="3%">&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif"></FONT></TD>
</TR>
<TR>
<TD colspan=3>&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD width="10%" valign="top" nowrap>
<FONT size=2 face="serif">32</FONT></TD>
<TD width="3%" valign="top">&nbsp;</TD>
<TD align=left valign="top">
<FONT size=2 face="serif">Certifications of Chief Executive Officer and Chief Financial Officer,
pursuant to Rule 13a - 14(b) and Section 1350 of Chapter 63 of Title 18 of the U.S. Code.</FONT></TD>
</TR>
<TR valign="bottom">
<TD width="10%" align=left nowrap>&nbsp;</TD>
<TD width="3%">&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif"></FONT></TD>
</TR>
<TR valign="bottom">
<TD width="10%" align=left nowrap>&nbsp;</TD>
<TD width="3%">&nbsp;</TD>
<TD align=left nowrap>
<FONT size=2 face="serif"></FONT></TD>
</TR>
</TABLE>
<BR>
<P align="center">
<FONT size=2 face="serif">29</FONT></P>

<HR noshade width="100%" size=4>


</BODY>

</HTML>

</TEXT>
</DOCUMENT>
